Literature DB >> 19365125

Botulinum neurotoxin: the ugly duckling.

Stauros Koussoulakos1.   

Abstract

This review presents a brief account of the most significant biological effects and clinical applications of botulinum neurotoxins, in a way comprehensive even for casual readers who are not familiar with the subject. The most toxic known substances in botulinum neurotoxins are polypeptides naturally synthesized by bacteria of the genus Clostridium. These polypeptides inhibit acetylcholine release at neuromuscular junctions, thus causing muscle paralysis involving both somatic and autonomic innervation. There is substantial evidence that this muscle-paralyzing feature of botulinum neurotoxins is useful for their beneficial influence on more than 50 pathological conditions such as spastic paralysis, cerebral palsy, focal dystonia, essential tremor, headache, incontinence and a variety of cosmetic interventions. Injection of adequate quantities of botulinum toxins in spastic muscles is considered as a highly hopeful procedure for the treatment of people who suffer from dystonia, cerebral palsy or have experienced a stroke. So far, numerous and reliable studies have established the safety and efficacy of botulinum neurotoxins and advocate wider clinical therapeutic and cosmetic applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365125     DOI: 10.1159/000210545

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

1.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

Authors:  Saedeh Dadgar; Zack Ramjan; Wely B Floriano
Journal:  J Med Chem       Date:  2013-03-29       Impact factor: 7.446

2.  Discovery of Dipeptides as Potent Botulinum Neurotoxin A Light-Chain Inhibitors.

Authors:  Martin Amezcua; Ricardo S Cruz; Alex Ku; Wilfred Moran; Marcos E Ortega; Nicholas T Salzameda
Journal:  ACS Med Chem Lett       Date:  2021-01-27       Impact factor: 4.345

Review 3.  Botulinum neurotoxin for pain management: insights from animal models.

Authors:  Flaminia Pavone; Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2010-12-21       Impact factor: 4.546

Review 4.  Botulinum Neurotoxin Type A in Neurology: Update.

Authors:  Marco Orsini; Marco Antonio Araujo Leite; Tae Mo Chung; Wladimir Bocca; Jano Alves de Souza; Olivia Gameiro de Souza; Rayele Priscila Moreira; Victor Hugo Bastos; Silmar Teixeira; Acary Bulle Oliveira; Bruno da Silva Moraes; André Palma Matta; Luis Jorge Jacinto
Journal:  Neurol Int       Date:  2015-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.